327 related articles for article (PubMed ID: 29200755)
1. Current and Future Perspectives of Stem Cell Therapy in Dermatology.
Prodinger CM; Reichelt J; Bauer JW; Laimer M
Ann Dermatol; 2017 Dec; 29(6):667-687. PubMed ID: 29200755
[TBL] [Abstract][Full Text] [Related]
2. Stem Cell Therapies for Epidermolysis Bullosa Treatment.
Niti A; Koliakos G; Michopoulou A
Bioengineering (Basel); 2023 Mar; 10(4):. PubMed ID: 37106609
[TBL] [Abstract][Full Text] [Related]
3. Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.
Vanden Oever M; Twaroski K; Osborn MJ; Wagner JE; Tolar J
Pediatr Res; 2018 Jan; 83(1-2):318-324. PubMed ID: 29593249
[TBL] [Abstract][Full Text] [Related]
4. Gene-edited cells: novel allogeneic gene/cell therapy for epidermolysis bullosa.
Gila F; Alamdari-Palangi V; Rafiee M; Jokar A; Ehtiaty S; Dianatinasab A; Khatami SH; Taheri-Anganeh M; Movahedpour A; Fallahi J
J Appl Genet; 2024 Mar; ():. PubMed ID: 38459407
[TBL] [Abstract][Full Text] [Related]
5. Functional therapies for cutaneous wound repair in epidermolysis bullosa.
Peking P; Koller U; Murauer EM
Adv Drug Deliv Rev; 2018 Apr; 129():330-343. PubMed ID: 29248480
[TBL] [Abstract][Full Text] [Related]
6. Management of severe epidermolysis bullosa by haematopoietic transplant: principles, perspectives and pitfalls.
Tolar J; Wagner JE
Exp Dermatol; 2012 Dec; 21(12):896-900. PubMed ID: 23016552
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy approaches for epidermolysis bullosa.
Ferrari S; Pellegrini G; Mavilio F; De Luca M
Clin Dermatol; 2005; 23(4):430-6. PubMed ID: 16023940
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
Cutlar L; Greiser U; Wang W
Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stem/Progenitor Cells Derived from Articular Cartilage, Synovial Membrane and Synovial Fluid for Cartilage Regeneration: Current Status and Future Perspectives.
Huang YZ; Xie HQ; Silini A; Parolini O; Zhang Y; Deng L; Huang YC
Stem Cell Rev Rep; 2017 Oct; 13(5):575-586. PubMed ID: 28721683
[TBL] [Abstract][Full Text] [Related]
10. Chemotaxis-driven disease-site targeting of therapeutic adult stem cells in dystrophic epidermolysis bullosa.
Alexeev V; Donahue A; Uitto J; Igoucheva O
Stem Cell Res Ther; 2016 Aug; 7(1):124. PubMed ID: 27568180
[TBL] [Abstract][Full Text] [Related]
11. EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure.
Uitto J; Bruckner-Tuderman L; McGrath JA; Riedl R; Robinson C
J Invest Dermatol; 2018 May; 138(5):1010-1016. PubMed ID: 29391251
[TBL] [Abstract][Full Text] [Related]
12. Placenta-based therapies for the treatment of epidermolysis bullosa.
Nevala-Plagemann C; Lee C; Tolar J
Cytotherapy; 2015 Jun; 17(6):786-795. PubMed ID: 25795271
[TBL] [Abstract][Full Text] [Related]
13. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H
J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899
[TBL] [Abstract][Full Text] [Related]
14. Stem cell therapies for recessive dystrophic epidermolysis bullosa.
Petrova A; Ilic D; McGrath JA
Br J Dermatol; 2010 Dec; 163(6):1149-56. PubMed ID: 20716209
[TBL] [Abstract][Full Text] [Related]
15. Thymosin β4: potential to treat epidermolysis bullosa and other severe dermal injuries.
Yang WS; Kang S; Sung J; Kleinman HK
Eur J Dermatol; 2019 Oct; 29(5):459-467. PubMed ID: 31649007
[TBL] [Abstract][Full Text] [Related]
16. Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.
Rashidghamat E; McGrath JA
Intractable Rare Dis Res; 2017 Feb; 6(1):6-20. PubMed ID: 28357176
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hereditary epidermolysis bullosa: updates and future prospects.
Hsu CK; Wang SP; Lee JY; McGrath JA
Am J Clin Dermatol; 2014 Feb; 15(1):1-6. PubMed ID: 24402870
[TBL] [Abstract][Full Text] [Related]
18. PDGF-AB and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells.
Chandrakanthan V; Yeola A; Kwan JC; Oliver RA; Qiao Q; Kang YC; Zarzour P; Beck D; Boelen L; Unnikrishnan A; Villanueva JE; Nunez AC; Knezevic K; Palu C; Nasrallah R; Carnell M; Macmillan A; Whan R; Yu Y; Hardy P; Grey ST; Gladbach A; Delerue F; Ittner L; Mobbs R; Walkley CR; Purton LE; Ward RL; Wong JW; Hesson LB; Walsh W; Pimanda JE
Proc Natl Acad Sci U S A; 2016 Apr; 113(16):E2306-15. PubMed ID: 27044077
[TBL] [Abstract][Full Text] [Related]
19. Stem Cells in Skin Regeneration, Wound Healing, and Their Clinical Applications.
Ojeh N; Pastar I; Tomic-Canic M; Stojadinovic O
Int J Mol Sci; 2015 Oct; 16(10):25476-501. PubMed ID: 26512657
[TBL] [Abstract][Full Text] [Related]
20. [Stem cell therapy for intractable skin diseases].
Tamai K
Nihon Rinsho; 2011 Dec; 69(12):2167-71. PubMed ID: 22242315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
